Descripción de la oferta

Requisitos

  • Sin Experiencia
  • Sin estudios
  • Salario a negociar
  • ARGENTINA - ARGENTINA

Descripción

JOB DESCRIPTION
Objectives and Scope of Position
Engage and educate investigators to enable successful clinical programs in early development until pivotal data release Provide insights and information to increase the effectiveness and impact of early clinical development strategy for the franchise Engage and partner with affiliates to enhance launch readiness Develop and facilitate a dynamic network of external stakeholders to ensure that Roche is the preferred partner
Summary of Main Responsibilities
1.Engage and educate investigators to enable successful clinical programs in early development until pivotal data release
Enables phase II/III studies by driving non study-execution activities such as scientific education on the protocol/development plan and liaison with key investigation sites
Suggests innovative approaches to investigation design, recruitment and data collection
Discusses and supports IIS, compassionate use programmes and data strategies that support access activities (until release of pivotal data)
Success measures: acceleration of patient benefit and trial development; ability to drive scientific investigation  
2.Provide insights and information to increase the effectiveness and impact of early clinical development strategy for the franchise
Maintains insight into internal and external developments and trends to contribute to the medical plan strategy and execution
Synthesises information from multiple sources and identifies areas that will have a substantive impact on clinical development strategy, communicate effectively across network
Identifies opportunities and new developments and feeds in insights to the organisation from a range of sources, including Therapeutic Area Experts (TAEs), real world evidence, scientific voice of customer, patients and patient groups
Success measures: speed of clinical development process, accuracy in describing the patient experience and unmet need, ensuring strategy is focused on the right things, increasing access  
3.Engage and partner with affiliates to enhance launch readiness in assigned countried
Accelerates the development of affiliate knowledge and understanding on medical issues, new therapeutic areas (TAs), new molecules, the disease state and the patient experience through education of affiliates and liaison with MSLs at the point of molecule hand-over
Identifies investment opportunities, creates and communicates compelling business cases based on clear appraisal of costs and benefits
Maintains constant communication and provides development to build understanding, alignment and collaboration of the affiliates with the global strategy, including discussion on the global medical plan
Support and accelerate MSL introduction into new TAs at the point of molecule hand-over by sharing local insight and facilitating collaboration with key external stakeholders, e.g. TAEs, societies, payers, and supporting connections and relationships between key experts and local affiliates
Supports the local implementation of field-based activities of the global medical plan in compliance with all local requirements and harnessing insight into different cultures and healthcare systems
Success measures: enabling affiliates to be effective in launch (due to increased affiliate confidence), satisfaction with support provided by the iMSL to the MSL and to the affiliate  
4.Develop and facilitate a dynamic network of external stakeholders to ensure that Roche is the preferred partner
Facilitates scientific knowledge exchange with global experts and across scientific networks at global and local level 
Establishes and maintains scientific collaborations with global thought leaders and global scientific societies, including patient organisations
Builds and strengthens a network of scientific collaborators with a focus on supporting progress in the disease area
Is visible as the ‘face of Roche’ with scientific stakeholders and an ambassador for the values of the organization
Facilitates understanding of Roche resources and connections to customers and identifies how they might provide solutions and support for the customer
Identifies and progresses key opportunities for increased collaboration and cooperation with and between internal and external stakeholders
Success measures: Roche as the partner of choice for external stakeholders; Roche iMSLs are perceived to bring value; advocacy for Roche amongst the scientific community  
Cross functional Support
Liaises with

Sobre la empresa

Roche is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange.

The company headquarters are located in Basel and the company has many pharmaceutical and diagnostic sites around the world – including: Tucson, AZ; Pleasanton, CA; Vacaville, California, Oceanside, California, Branchburg, NJ; Indianapolis, Indiana; Florence, South Carolina; and Ponce, Puerto Rico in the US; Welwyn Garden City and Burgess Hill in the UK; Clarecastle in Ireland; Mannheim and Penzberg in Germany; Mississauga and Laval in Canada; Shanghai in China; Mumbai & Hyderabad in India; São Paulo and Rio de Janeiro, Brazil; Segrate, Milan in Italy; Johannesburg in South Africa; Karachi, Islamabad and Lahore in Pakistan. There are 26 manufacturing sites worldwide.

Empresas en el sector

Colmenas donde puedes encontrar esta oferta de empleo